Combination immunotherapy with Interleukin-2 and CTLA-4 blockade decreases tumor growth and improves overall survival

Benzer Materyaller

• Combination immunotherapy with anti-CTLA-4 and interleukin-2 redirects regulatory T cells into tumor-draining lymph nodes and expands anti-tumor CD8+ T cells in the tumor microenvironment
  Yazar:: Broucek, Joseph, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Role of dose selection in successful interleukin-2 immunotherapy: solving the Goldilock’s Complex
  Yazar:: Zloza, Andrew, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade
  Yazar:: Kohlhapp, Frederick J, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Acute viral infection results in a PD-1-dependent loss of anti-tumor CD8+ T cell responses: implications for tumor immunotherapy
  Yazar:: Kohlhapp, Frederick, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Interleukin-2 alters distribution of CD144 (VE-cadherin) in endothelial cells
  Yazar:: Kim, Dae Won, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)